Navigation Links
FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Date:4/22/2013

the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem completed an FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig 's disease, in February 2013, and has received FDA approval to begin Phase II. Neuralstem has been awarded orphan status designation by the FDA for its ALS cell therapy.

In addition to ALS, the company is also targeting major central nervous system conditions with its NSI-566 cell therapy platform, including spinal cord injury, ischemic stroke and glioblastoma (brain cancer). The company received approval to commence a Phase I safety trial in chronic spinal cord injury in January 2013.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions. The company is in a Phase Ib safety trial evaluating NSI-189, its first neurogenic small molecule compound, for the treatment of major depressive disorder (MDD). Additional indications could include traumatic brain injury (TBI), Alzheimer's disease, and post-traumatic stress disorder (PTSD).

For more information, please visit www.neuralstem.com or connect with us on Twitter, Facebook and LinkedIn

Cautionary Statement Regarding Forward Looking Information      
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
2. FDA Approves NDA Supported By MedAvante Central Ratings
3. Cardinal Health Board Of Directors Approves Cash Dividend; Authorizes New $750 Million Share Repurchase Program
4. Neuralstem Updates ALS Stem Cell Trial Progress
5. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
6. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
7. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
8. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
9. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
10. Neuralstem Announces Proposed Public Offering
11. Neuralstem to Raise $7.0 Million in Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , Spanien, May 6, 2015 /PRNewswire/ ... Sparte Veterinärmedizin von ESTEVE will ... eine führende Rolle auf dem europäischen Markt ... Zusammenschluss übernimmt ECUPHAR alle Vermögensgüter und Beschäftigten ... Wochen dem neuen Unternehmen angegliedert werden. Da ...
(Date:5/5/2015)... 5, 2015  CorMedix Inc. (NYSE MKT: CRMD), a ... for the treatment of infectious diseases, announced that it ... 7.  Randy Milby , Chief Executive Officer of ... May 8 at 9:00 a.m. EDT.  ... call 1-877-407-8031 (U.S.), 1-201-689-8031 (outside the U.S.). All participants ...
(Date:5/5/2015)... 2015 Silver Creek Pharmaceuticals, Inc. announced today ... grant from the National Institute of Health (NIH). ... Francisco based biotechnology company that discovers and ... by disease. This award will be used to advance ... following a heart attack. Silver Creek,s Smart ...
Breaking Medicine Technology:ECUPHAR tritt mit ESTEVE in den spanischen und südamerikanischen Markt ein 2CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015 2Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2
... 1, 2011 For the first ... endoscopic spinal surgery, showing the novel pain therapy ... endoscopic facet joint denervation, otherwise known as rhizotomy. ... launched in spring 2011, it completes the joimax® ...
... Time comes to an end on Sunday, Nov. 6, and adjusting ... Americans say that they experience a sleep problem every night or ... in America poll, and for those individuals the time change can ... into bed for not only an extra hour, but stay asleep ...
Cached Medicine Technology:joimax® Launches Numerous Innovations at NASS Chicago From November 2 - 4, 2011 2Keep the Time Change From Disrupting Your Rest With Sleep Formula 39™ 2
(Date:5/6/2015)... 2015 LINET Americas has been awarded ... the small business category. The award was given for ... Award is given on an annual basis to foreign ... contributions to philanthropy. Since 1998, the Charlotte International ... the Mayor’s International Community Awards. The award was presented ...
(Date:5/6/2015)... 06, 2015 “ Radiation Island ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... best graphic games on iOS. , Touted as one of ... It’s loved by users, which is obvious because of its ...
(Date:5/5/2015)... With ProPoint: Hand Drawn, users can point, underline, ... X . With ProPoint: Hand Drawn, users can also ... customize each preset all with a click of a mouse. ... fully customizable effect presets all within Final Cut Pro X. ... underlines, and more. , ProPoint: Hand Drawn on-screen controls ...
(Date:5/5/2015)... The Journal of Pain Research ... to improve the management of chronic non-cancer pain ... ACCORD program ” , As corresponding author Professor ... patients and family members, managers, and researcher, identified ... gap, “work in silos”, lack of awareness regarding ...
(Date:5/5/2015)... 2015 “Given that Hispanics are one in ... CDC report are a major step in the arsenal of ... For the past 30 years, data have accumulated that the ... we see the urgency and the need to create new ... outcomes for all,” said Jane L. Delgado, PhD, MS, President ...
Breaking Medicine News(10 mins):Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2Health News:Top Grossing iPhone Game, Radiation Island, Was Featured on NewsWatch 2Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Priority interventions in chronic non-cancer pain published by Dove Medical Press 2Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2
... Clarient, Inc. (Nasdaq: CLRT ... pathologists, oncologists and the pharmaceutical industry, today announced that the Company ... Investments reconstitutes its comprehensive set of U.S. and global equity indices ... June 12 on www.russell.com . , , ...
... to hit market in September , , BOSTON, June 29 ... Times bestselling author and renowned wellness coach from NBC,s ... of weight-loss products in partnership with ThinCare(TM) International, LLC. The new ... Drug Stores Marketplace in Boston, Massachusetts on June 29, 2009. Scientifically ...
... , ... keep your pet healthy and happy and is more likely to avoid serious and costly health ... , ... pet health care can prevent expensive vet bills in the future, pet owners are reminded, as everyone ...
... ... an authorized representative agreement with SupplyCore Middle East (SCME). The agreement allows SCME to ... Medical decontamination equipment throughout the Middle East and North Africa (MENA). , ... (Vocus) June 29, 2009 -- ...
... ... MD Now Urgent Care: MD Now Urgent Care Medical Centers of Palm Beach County Florida has ... by the Urgent Care Association of America. , ... Palm Beach Gardens, FL (PRWEB) June 29, 2009 -- MD Now Urgent Care Medical Centers ...
... ... new coalition under the leadership of Matthias Rath, MD, is spearheading an online grass roots ... the rights of Americans to access safe, science-based, natural health alternatives. , ... Santa Clara, CA (PRWEB) June 29, 2009 -- ...
Cached Medicine News:Health News:Clarient Set to Join Russell 3000 Index 2Health News:Clarient Set to Join Russell 3000 Index 3Health News:Clarient Set to Join Russell 3000 Index 4Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 2Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 3Health News:Proactive Pet Care Essential in Low Cash Times, Says NOAH 2Health News:Proactive Pet Care Essential in Low Cash Times, Says NOAH 3Health News:Midbrook Partners with Supply Core Middle East to Provide Water Bottling and Medical Decontamination Equipment to the Middle East and North Africa 2Health News:Midbrook Partners with Supply Core Middle East to Provide Water Bottling and Medical Decontamination Equipment to the Middle East and North Africa 3Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 2Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 3Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 2Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 3Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 4Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 5
... RNA from agarose gels to hybridization membranes ... speed and efficiency of transfer by allowing ... ,Part of an integrated system allowing electrophoresis, ... 2.5 hours, versus 29 hours required for ...
PosiBlot 30-30 Masks...
... Rapid Downward Transfer Kit High resolution ... hour., Rapid ,Unique downward capillary ... hour and neutral ,(SSC) transfers in three ... device requires less buffer and blotting paper. ...
... of using the Antigen-Antibody Pens-Using a proprietary ... developed specialized fountain pens, called Antigen-Antibody pens-TM, ... write/mark the blotting membranes in any form ... antigen-bonded colored dyes helps to see antigen ...
Medicine Products: